|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 14/55 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Patento numeris | 3150218 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16195608.1 |
| Europos patento paraiškos padavimo data | 2008-09-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 994717 P | 2007-09-21 | US |
| (72) |
Morrison, Sherie L. , US
Huang, Tzu-Hsuan , US
Xuan, Caiyun , US
|
| (73) |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ,
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200,
US
|
| (54) | TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES |
| TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES |